EGFR is the representative receptor underlying various tumor phenotypes, such as proliferation, anti-apoptotic advantage, migration, and invasion in malignant tumors including pancreatic cancers [16–19]. This evidence concerns the gene EGFR and familial pancreatic carcinoma.